Lymphocyte Subset Counts in CAPD Patients in Relation to Administration of Recombinant Human Erythropoietin and Angiotensin-Converting Enzyme Inhibitors

Yorioka N. , Hamaguchi N. , Tagasugi N. , Shigememoto K. , Harada S. , Fujiwara K. Effect of recombinant human erythropoietin administration on immunological indices in patients undergoing chronic hemodialysis. Nippon Jinzo Gakkai Shi 1993; 35: 981–8.

Barany P. , Fehrman I. , Godoy C. Long-term effects on lymphocytotoxic antibodies and immune reactivity in hemodialysis patients treated with recombinant human erythropoietin. Clin Nephrol 1992; 37: 90–6.

Franek E. , Wiecek A. , Jagoda K. , Marcinkowski W. , Holowiecki J. , Kokot F. Influence of short-term rHuEPO therapy on selected parameters of immunity in nondialyzed uraemic patients (NDP) (Abstract). Aktuality v Nefrologii 1998; 4(1): 34.

Wiecek A. , Kyrcz–Krzemien S. , Franek E. , Kokot F. , Holowiecki J. , Klin M. Influence of short-term erythropoietin therapy on selected parameters of cell mediated and humoral immunity in haemodialyzed uraemic patients (in Polish). Pol Arch Med Wewn 1995; 93: 41–7.

Stefansson B. , Johnsen S.A. , Herlitz H. , Persson I.B. , Aurell M. Effects of bradykinin on T-lymphocyte proliferation (Abstract). Nephrol Dial Transplant 2000; 15: A42.

Rysz J. , Majewska E. , Baj Z. , Luciak M. The influence of hemodialysis on peripheral blood lymphocyte apoptosis. In: Abstracts. Proceedings of the XXXVII Congress of the European Renal Association—European Dialysis and Transplantation Association, Nice, September 17–20, 2000; Stockholm: Gambro Renal Care; 2000: 46.

Tarng D.C. , Huang T.P. , Doong T.I. Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin. Nephron 1998; 78: 253–9.

Palop L. , Martinez J.A. Cross-sectional assessment of nutritional and immune status in renal patients undergoing continuous ambulatory peritoneal dialysis. Am J Clin Nutr 1997; 66: 498S–503S.

Langhoff E. , Ladefoged J. In vitro natural killer and killer cell function in uremia. Int Arch Allergy Appl Immunol 1984; 74: 241–5.

Navarro J.F. , Macia M.L. , Mora–Fernández C. , Gallego E. , Chahin J. , Méndez M.L. Effects of angiotensin-converting enzyme inhibitors on anemia and erythropoietin requirements in peritoneal dialysis patients. Adv Perit Dial 1997; 13: 257–9.